TG Therapeutics, Inc. (TGTX)
54.28
+0.35
(+0.65%)
USD |
NASDAQ |
Aug 31, 16:00
54.28
0.00 (0.00%)
After-Hours: 20:00
TG Therapeutics Cash and Short Term Investments (Quarterly) : 552.25M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 552.25M |
| March 31, 2026 | 514.43M |
| December 31, 2025 | 141.97M |
| September 30, 2025 | 131.58M |
| June 30, 2025 | 251.87M |
| March 31, 2025 | 276.24M |
| December 31, 2024 | 311.00M |
| September 30, 2024 | 341.04M |
| June 30, 2024 | 217.25M |
| March 31, 2024 | 209.78M |
| December 31, 2023 | 217.51M |
| September 30, 2023 | 229.16M |
| June 30, 2023 | 144.90M |
| March 31, 2023 | 139.71M |
| December 31, 2022 | 161.68M |
| September 30, 2022 | 175.94M |
| June 30, 2022 | 195.71M |
| March 31, 2022 | 233.20M |
| December 31, 2021 | 314.76M |
| September 30, 2021 | 356.85M |
| June 30, 2021 | 443.46M |
| March 31, 2021 | 523.85M |
| December 31, 2020 | 605.43M |
| September 30, 2020 | 254.15M |
| June 30, 2020 | 275.57M |
| Date | Value |
|---|---|
| March 31, 2020 | 78.34M |
| December 31, 2019 | 140.44M |
| September 30, 2019 | 72.45M |
| June 30, 2019 | 84.98M |
| March 31, 2019 | 92.47M |
| December 31, 2018 | 68.81M |
| September 30, 2018 | 97.74M |
| June 30, 2018 | 126.24M |
| March 31, 2018 | 109.08M |
| December 31, 2017 | 84.72M |
| September 30, 2017 | 91.84M |
| June 30, 2017 | 86.41M |
| March 31, 2017 | 109.46M |
| December 31, 2016 | 44.89M |
| September 30, 2016 | 60.60M |
| June 30, 2016 | 54.26M |
| March 31, 2016 | 58.70M |
| December 31, 2015 | 77.23M |
| September 30, 2015 | 94.16M |
| June 30, 2015 | 92.07M |
| March 31, 2015 | 105.14M |
| December 31, 2014 | 78.78M |
| September 30, 2014 | 67.24M |
| June 30, 2014 | 45.04M |
| March 31, 2014 | 53.50M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 845.63M |
| MAIA Biotechnology, Inc. | 27.60M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |
| BioMarin Pharmaceutical, Inc. | 874.00M |
| Cytokinetics, Inc. | 1.169B |